Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Gefiltert nach market cap "Mega ≥$200B", No report yet: 55 match(Filter löschen).

# Titel Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Analyse FY
1 Visa Inc. Class A V · USA $684B
95/100 Exzellent
35.7%low 18.2% 10 yr+ 0.1× 81% FY2025
2 KLA Corporation KLAC · USA $239B
93/100 Exzellent
55.9%low 44.2% 10 yr+ 0.2× 61% FY2026
3 Kweichow Moutai Co Ltd 600519 · Shanghai $236B
93/100 Exzellent
30.8%low 22.9% 10 yr+ Net cash 90% FY2025
4 ASML Holding NV ADR ASML · USA $626B
92/100 Exzellent
36.5%low 15.9% 10 yr+ Net cash 49% FY2025
5 Applied Materials Inc AMAT · USA $403B
92/100 Exzellent
38.9%low 23.8% 10 yr+ Net cash 46% FY2025
6 Roche Holding AG ROG · SW $326B
92/100 Exzellent
39.6%low 26.1% 10 yr+ 0.5× 72% FY2025
7 Microsoft Corporation MSFT · USA $3.5T
91/100 Exzellent
34.6%low 20.0% 10 yr+ 0.1× 68% FY2026
8 Lam Research Corp LRCX · USA $367B
90/100 Exzellent
48.3%low 24.3% 10 yr+ Net cash 47% FY2026
9 American Express Company AXP · USA $227B
89/100 Exzellent
27.8%low 13.6% 10 yr+ 0.3× 87% FY2025
10 LOréal S.A. OR · Paris $222B
88/100 Exzellent
16.5%low 12.3% 10 yr+ 0.1× 73% FY2025
11 Novo Nordisk A/S NOVO-B · CO $210B
88/100 Exzellent
59.3%low 52.8% 10 yr+ 0.5× 84% FY2025
12 Cisco Systems Inc CSCO · USA $457B
87/100 Exzellent
22.4%low 0.3% 10 yr+ 0.3× 63% FY2025
13 Costco Wholesale Corp COST · USA $422B
87/100 Exzellent
25.4%low 19.5% 10 yr+ Net cash 13% FY2025
14 Mastercard Inc MA · USA $502B
86/100 Exzellent
60.0%low 60.0% 10 yr+ 1.0× 77% FY2025
15 Alphabet Inc Class C GOOG · USA $4.4T
85/100 Exzellent
21.7%low 8.3% 10 yr+ Net cash 57% FY2025
16 UnitedHealth Group Incorporated UNH · USA $376B
84/100 Exzellent
21.4%low 12.8% 10 yr+ 0.5× 23% FY2025
17 Procter & Gamble Company PG · USA $335B
84/100 Exzellent
26.6%low 8.3% 10 yr+ 0.4× 50% FY2026
18 Apple Inc. AAPL · USA $4.5T
83/100 Exzellent
54.7%low 35.6% 10 yr+ 0.8× 41% FY2025
19 LVMH Moët Hennessy - Louis Vuitton MC · Paris $253B
83/100 Exzellent
19.2%low 12.1% 10 yr+ 0.3× 67% FY2025
20 Johnson & Johnson JNJ · USA $618B
82/100 Exzellent
25.5%low 2.2% 10 yr+ 0.3× 69% FY2025
21 Texas Instruments Incorporated TXN · USA $252B
82/100 Exzellent
46.2%low 28.4% 10 yr+ 0.6× 63% FY2025
22 Nestle S.A. NESN · SW $265B
80/100 Exzellent
23.7%low 11.7% 10 yr+ 1.6× 48% FY2025
23 The Coca-Cola Company KO · USA $377B
79/100 Stark
36.8%low 7.3% 10 yr+ 1.0× 61% FY2025
24 The Home Depot Inc HD · USA $337B
78/100 Stark
60.0%low 60.0% 10 yr+ 5.0× 34% FY2026
25 Novartis AG NOVN · SW $306B
78/100 Stark
20.9%low 9.0% 10 yr+ 0.6× 71% FY2025
26 SAP SE ADR SAP · USA $231B
77/100 Stark
12.6%low 5.7% 10 yr+ Net cash 71% FY2025
27 Philip Morris International Inc PM · USA $297B
76/100 Stark
49.2%low 24.0% 10 yr+ 60% FY2025
28 Netflix Inc NFLX · USA $299B
74/100 Stark
25.2%low 7.0% 10 yr+ 0.2× 40% FY2025
29 AbbVie Inc ABBV · USA $443B
73/100 Stark
54.6%low 35.2% 10 yr+ 71% FY2025
30 Merck & Company Inc MRK · USA $307B
71/100 Stark
24.4%low 1.0% 10 yr+ 0.7× 70% FY2025
31 International Business Machines IBM · USA $211B
71/100 Stark
34.1%low 7.5% 10 yr+ 1.6× 52% FY2025
32 MediaTek Inc 2454 · Taiwan $226B
70/100 Stark
17.2%low 7.4% 10 yr+ Net cash 41% FY2025
33 Walmart Inc. WMT · USA $885B
69/100 Stark
16.0%low 8.4% 10 yr+ 0.6× 25% FY2026
34 Thermo Fisher Scientific Inc TMO · USA $213B
69/100 Stark
13.3%low 8.8% 10 yr+ 0.5× 44% FY2025
35 Morgan Stanley MS · USA $331B
68/100 Stark
11.1%low 7.9% 10 yr+ Net cash 77% FY2025
36 Amgen Inc AMGN · USA $208B
67/100 Stark
51.4%low 7.8% 10 yr+ 5.3× 76% FY2025
37 Oracle Corporation ORCL · USA $374B
65/100 Stark
46.3%low 7.8% 10 yr+ 2.9× 76% FY2026
38 AstraZeneca PLC AZN · LSE $249B
64/100 Mittel
15.3%low 0.3% 10 yr+ 0.5× 72% FY2025
39 Siemens AG ADR SIEGY · USA $249B
63/100 Mittel
13.4%low 7.6% 10 yr+ 0.6× 35% FY2025
40 BHP Group Limited BHP · LSE $202B
62/100 Mittel
18.8%low -12.0% 9 yr 0.3× 72% FY2025
41 Caterpillar Inc CAT · USA $375B
60/100 Mittel
34.1%low -0.5% 9 yr 1.6× 31% FY2025
42 Arm Holdings plc American Depositary Shares ARM · USA $256B
59/100 Mittel
11.3%low 5.8% 6 yr Net cash 92% FY2026
43 Eli Lilly and Company LLY · USA $1.0T
58/100 Mittel
45.5%low -1.8% 8 yr 1.3× 78% FY2025
44 Samsung Electronics Co Ltd 005930 · Korea $1.7T
57/100 Mittel
12.1%low 4.1% 10 yr+ Net cash 38% FY2025
45 Dell Technologies Inc DELL · USA $262B
57/100 Mittel
20.6%low -4.7% 7 yr 23% FY2026
46 Goldman Sachs Group Inc GS · USA $309B
55/100 Mittel
10.7%low 5.2% 10 yr+ Net cash 65% FY2025
47 CNOOC Limited 600938 · Shanghai $215B
52/100 Mittel
12.9%low 0.2% 10 yr+ Net cash 74% FY2025
48 Linde plc Ordinary Shares LIN · USA $221B
48/100 Eher schwach
13.9%low 4.7% 10 yr+ 0.6× 32% FY2025
49 RTX Corporation RTX · USA $290B
38/100 Eher schwach
9.2%low -4.9% 5 yr 0.5× 21% FY2025
50 Shell PLC ADR SHEL · USA $252B
27/100 Schwach
7.9%low -14.0% 5 yr 0.4× 11% FY2025
51 Shell plc SHEL · LSE $238B
27/100 Schwach
7.9%low -14.0% 5 yr 0.4× 11% FY2025
52 Shell PLC SHELL · Amsterdam $237B
27/100 Schwach
7.9%low -13.9% 5 yr 0.4× 11% FY2025
53 SK Hynix Inc 000660 · Korea $1.2T
24/100 Schwach
15.5%low -17.0% 2 yr 41% FY2025
54 Micron Technology Inc MU · USA $927B
23/100 Schwach
12.8%low -13.2% 2 yr 0.1× 33% FY2025
55 GE Aerospace GE · USA $374B
21/100 Schwach
5.1%low -43.4% 4 yr 0.4× 28% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.